Filing Details

Accession Number:
0000711377-10-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-07 17:42:41
Reporting Period:
2010-10-05
Filing Date:
2010-10-07
Accepted Time:
2010-10-07 17:42:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-05 693 $9.02 10,967 No 4 M Direct
Common Stock Disposition 2010-10-05 683 $34.11 10,274 No 4 S Direct
Common Stock Acquisiton 2010-10-05 2,086 $13.55 12,360 No 4 M Direct
Common Stock Disposition 2010-10-05 2,086 $34.11 10,274 No 4 S Direct
Common Stock Acquisiton 2010-10-06 137 $13.55 10,411 No 4 M Direct
Common Stock Disposition 2010-10-06 137 $34.05 10,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-05 693 $0.00 693 $9.02
Common Stock Common Stock Options (Right to buy) Disposition 2010-10-05 2,086 $0.00 2,086 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-06 137 $0.00 137 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,745 2011-11-03 No 4 M Direct
38,659 2012-08-09 No 4 M Direct
38,522 2012-08-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,564 Indirect Held by Neogen Corporation 401-K Plan
Footnotes
  1. The options were granted 11/3/06 as ISO options and became exercisable 20% yearly thereafter.
  2. The options were granted 8/9/07 as Non-Qualified optins and became exercisable 20% yearly thereafter.